Proteomics Market size to Reach USD 1,42,406 Million by 2034

According to latest report by Statifacts, the global proteomics market size was exhibited at USD 39,787 million in 2024 and is projected to hit around USD 1,42,406 million by 2034, growing at a CAGR of 13.6% during the forecast period 2024 to 2034.

The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report@
https://www.statifacts.com/download-product/6993

The rising prevalence of chronic & infectious diseases, the increasing demand for rapid & advanced diagnostic solutions in target disease treatment, and the growing demand for personalized medicine are some of the factors contributing to market growth. Moreover, technological advancements in protein analysis further propel the growth.

The rising prevalence of chronic and infectious diseases drives proteomics market growth. The WHO predicts that there will be over 35 million new cancer cases by 2050, a 77% surge from the approximately 20 million cases estimated in 2022. Moreover, this rise in the disease prevalence increases the demand for pathogenesis research, and advanced diagnostics and therapeutics. For instance, according to research published in Nature Communications in July 2024, scientists used a proteomics-based approach to identify effectors secreted by Rickettsia spp, thereby understanding the host-pathogen interface.

In addition, in a recent study published in the journal Nature Medicine in August 2024, scientists developed a proteomic aging clock using plasma proteins. This clock helps measure age and predict the risk of age-related diseases, multimorbidity, and mortality across diverse populations. Moreover, emerging technology such as top-down proteomics helps understand the role of proteoforms in disease mechanisms and precision medicine, aiding in bridging the gap between genotypes and phenotypes.

The integration of advanced high-throughput technologies, such as next-generation mass spectrometers and multi-omics approaches, has contributed to enhanced sensitivity, accuracy, and pace of protein analysis. These technologies enable researchers to conduct high-throughput analyses, enabling more comprehensive studies of protein interactions and functions. In addition, developments in sample analysis methods and software tools for data analysis have streamlined workflows, further delivering high throughput results and making it easier to interpret vast amounts of data generated from proteomic experiments.

For instance, according to an article published in the journal Nature Protocols in August 2024, researchers from Northeastern University, Boston, U.S., have developed a nano-proteomic sample preparation (nPOP) method for single-cell proteomics by mass spectrometry. This method is likely to increase throughput by the parallel preparation of numerous single cells in nanoliter-volume droplets deposited on glass slides.

Furthermore, the COVID-19 pandemic significantly impacted the proteomics market. Lockdowns and restrictions disrupted the manufacturing and distribution of essential reagents and instruments used in proteomic studies. However, the pandemic has driven innovation in proteomics technologies and methodologies. The demand for rapid and accurate detection methods has led to advancements in mass spectrometry and other analytical techniques, with an increased focus on the development of targeted therapies and vaccines.

View Detailed Dataset (Price: USD 1550) ; https://www.statifacts.com/outlook/proteomics-market

Impact of AI on the Proteomics Market

Artificial Intelligence (AI) is transforming the proteomics market by addressing challenges in analyzing complex protein datasets and enhancing the understanding of protein functions and interactions.

AI-driven algorithms enable faster and more accurate interpretation of mass spectrometry data, facilitating protein identification and quantification. Machine learning models can predict protein structures, functions, and interactions, expediting drug discovery and biomarker identification. By integrating multi-omics data, AI helps uncover disease mechanisms, supporting personalized medicine approaches.

In proteomics research, AI improves data quality and reproducibility by identifying anomalies and standardizing workflows. Predictive analytics optimize experimental design, saving time and resources. Additionally, AI-powered tools assist in automating protein annotation and database management, reducing human errors.

AI also plays a pivotal role in advancing clinical applications of proteomics, such as early disease detection and targeted therapy development. Its ability to process and analyze vast datasets accelerates the translation of proteomics research into actionable insights, fostering innovation across healthcare and biotechnology.

As AI continues to evolve, its integration into the proteomics market enhances scalability, precision, and accessibility, positioning it as a critical driver of growth and discovery in this field.

Market Concentration & Characteristics

The proteomics market is experiencing a significant degree of innovation driven by technological advancements in mass spectrometry and next generation sequencing technology. Moreover, the integration of artificial intelligence and the development of high-throughput technologies that allow for rapid sample processing and analysis, improving reproducibility and efficiency, further driving market growth.

The industry is witnessing a significant amount of merger and acquisition activity among major players. This is driven by various factors, such as the expansion of product offerings and the need to consolidate in a fast-growing market. For instance, in January 2024, Standard BioTools merged with SomaLogic, thereby strengthening the innovation in multi-omics technology.

Regulatory bodies such as the U.S. FDA, the EMA, etc., establish guidelines that govern the development and commercialization of proteomics technologies and products. These regulations ensure that proteomics solutions meet safety, efficacy, and quality standards before they can be used in clinical settings or marketed to consumers. These agencies are increasingly emphasizing standardization in proteomics workflows to ensure reproducibility and comparability across studies.

Key players are adopting the strategy of increasing production capacity and expanding their market reach to improve the availability of their products and services in diverse geographic areas. Additionally, companies are launching new platforms to strengthen their product and service portfolios.

The industry is witnessing moderate regional expansion, driven by an increasing customer base for proteomics products & services. For instance, in January 2024, Biognosys expanded its presence in the U.S. by opening a new contract research facility focused on proteomics services. This expansion reflects the increasing demand for specialized proteomic services that support drug development processes.

Immediate Delivery is Available | Get Full Report Access(Price: USD 1550);https://www.statifacts.com/order-report/6993

Proteomics Market Companies:
• Agilent Technologies
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Genzyme Corporation
• GE Healthcare
• Bio-Rad Laboratories, Inc.
• Affymetrix Inc.
• Bruker Corporation
• Horiba, Ltd.
• Waters Corporation

Proteomics Market Segmentation:

By Equipment

• Chromatography
• Mass Spectroscopy
• Protein Microarray
• X-ray Crystallography
• Protein fractionation
• Others

By Services

• Laboratory Service
• Data Analysis and Services

By Application

• Drug Discovery
• Clinical Diagnosis
• Others

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors

• Provision of market value (USD Billion) data for each segment and sub-segment

• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

• Includes in-depth analysis of the market from various perspectives through Porter's five forces analysis

• Provides insight into the market through Value Chain

• Market dynamics scenario, along with growth opportunities of the market in the years to come

• 6-month post-sales analyst support

Immediate Delivery is Available | Get Full Report Access@ (Price: USD 1550); https://www.statifacts.com/order-report/6993

You can place an order or ask any questions, please feel free to contact at sales@statifacts.com| +44 7383 092 044

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬:
Ballindamm 22, 20095 Hamburg, Germany
Email: sales@statifacts.com
Europe : +44 7383 092 044

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:
Statifacts is a leading provider of comprehensive market research and analytics services, offering over 1,000,000 market and customer data sets across various industries. Their platform enables businesses to make informed strategic decisions by providing full access to statistics, downloadable in formats such as XLS, PDF, and PNG.

Visit Our Sitemap: https://www.statifacts.com/outlook/sitemap.xml

This release was published on openPR.